FDA primed to consider Pfizer COVID-19 vaccine for younger kids

Oct 25, 2021

Also, Moderna announces promising immune response and safety data for its vaccine in kids ages 6 to 11.

Stephanie Soucheray | News Reporter | CIDRAP NewsOct 25, 2021Also, Moderna announces promising immune response and safety data for its vaccine in kids ages 6 to 11.Read More

Leave a Reply

Your email address will not be published.